SPAG5 and cancer: We propose that expression of astrin-2 endows cancer cells with the ability to proliferate, despite a dysregulated coupling between mitochondrial metabolism and the cell cycle, making CLUH a possible novel therapeutic target in cancers overexpressing SPAG5.